| Project/Area Number |
24KJ0709
|
|---|
| Research Category |
Grant-in-Aid for JSPS Fellows
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 国内 |
|---|
| Review Section |
Basic Section 27040:Biofunction and bioprocess engineering-related
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
戴 以周 東京大学, 大学院工学系研究科(工学部), 特別研究員(DC2)
|
|---|
| Project Period (FY) |
2024-04-23 – 2026-03-31
|
| Project Status |
Granted (Fiscal Year 2024)
|
| Budget Amount *help |
¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2025: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2024: ¥800,000 (Direct Cost: ¥800,000)
|
|---|
| Outline of Research at the Start |
For the first time, we studied the therapeutic effect and its mechanism of our recently developed thermally stable oligonucleotide-based mimetics of hepatocyte growth factor (HGF DNA Aptamer) to prevent PPA while optimizing its therapeutic efficacy and further developing it to a bioactive material.
|
